Diovan is now the first angiotensin receptor blocker APPROVED for heart failure

Diovan is now the first angiotensin receptor blocker APPROVED for heart failure...for patients who can't take an ACE inhibitor.

Diovan (valsartan) reduces mortality by 33% in patients not getting an ACE inhibitor. It also improves ejection fraction...reduces symptoms...and decreases hospitalizations.

Even though Diovan is the only angiotensin receptor blocker approved, other ARBs probably help.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote